Influenza Vaccine Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Report ID: 54191 | Published Date: Oct 2024 | No. of Page: 109 | Base Year: 2023 | Rating: 4.4 | Webstory: Check our Web story
Table of Contents
1  RESEARCH SCOPE
    1.1 Research Product Definition
    1.2 Research Segmentation
        1.2.1 Product Type
        1.2.2 Main product Type of Major Players
    1.3 Demand Overview
    1.4 Research Methodology
2 GLOBAL INFLUENZA VACCINE INDUSTRY
    2.1 Summary about Influenza Vaccine Industry
    2.2 Influenza Vaccine Market Trends
        2.2.1 Influenza Vaccine Production & Consumption Trends
        2.2.2 Influenza Vaccine Demand Structure Trends
    2.3 Influenza Vaccine Cost & Price
3  MARKET DYNAMICS
    3.1 Manufacturing & Purchasing Behavior in 2020
    3.2 Market Development under the Impact of COVID-19
        3.2.1 Drivers
        3.2.2 Restraints
        3.2.3 Opportunity
        3.2.4 Risk
4  GLOBAL MARKET SEGMENTATION
    4.1 Region Segmentation (2017 to 2021f)
        4.1.1 North America (U.S., Canada and Mexico)
        4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
        4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
        4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
        4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
    4.2 Product Type Segmentation (2017 to 2021f)
        4.2.1 Trivalent Influenza Vaccine
        4.2.2 Quadrivalent Influenza Vaccine
        4.2.3 Others
    4.3 Consumption Segmentation (2017 to 2021f)
        4.3.1 Children
        4.3.2 Adults
        4.3.3 Elderly
        4.3.4 Pregnancy
5  NORTH AMERICA MARKET SEGMENT
    5.1 Region Segmentation (2017 to 2021f)
        5.1.1 U.S.
        5.1.2 Canada
        5.1.3 Mexico
    5.2 Product Type Segmentation (2017 to 2021f)
        5.2.1 Trivalent Influenza Vaccine
        5.2.2 Quadrivalent Influenza Vaccine
        5.2.3 Others
    5.3 Consumption Segmentation (2017 to 2021f)
        5.3.1 Children
        5.3.2 Adults
        5.3.3 Elderly
        5.3.4 Pregnancy
    5.4 Impact of COVID-19 in North America
6  EUROPE MARKET SEGMENTATION
    6.1 Region Segmentation (2017 to 2021f)
        6.1.1 Germany
        6.1.2 UK
        6.1.3 France
        6.1.4 Italy
        6.1.5 Rest of Europe
    6.2 Product Type Segmentation (2017 to 2021f)
        6.2.1 Trivalent Influenza Vaccine
        6.2.2 Quadrivalent Influenza Vaccine
        6.2.3 Others
    6.3 Consumption Segmentation (2017 to 2021f)
        6.3.1 Children
        6.3.2 Adults
        6.3.3 Elderly
        6.3.4 Pregnancy
    6.4  Impact of COVID-19 in Europe
7  ASIA-PACIFIC MARKET SEGMENTATION
    7.1 Region Segmentation (2017 to 2021f)
        7.1.1 China
        7.1.2 India
        7.1.3 Japan
        7.1.4 South Korea
        7.1.5 Southeast Asia
        7.1.6 Australia
        7.1.7 Rest of Asia Pacific
    7.2 Product Type Segmentation (2017 to 2021f)
        7.2.1 Trivalent Influenza Vaccine
        7.2.2 Quadrivalent Influenza Vaccine
        7.2.3 Others
    7.3 Consumption Segmentation (2017 to 2021f)
        7.3.1 Children
        7.3.2 Adults
        7.3.3 Elderly
        7.3.4 Pregnancy
    7.4  Impact of COVID-19 in Europe
8  SOUTH AMERICA MARKET SEGMENTATION
    8.1 Region Segmentation (2017 to 2021f)
        8.1.1 Brazil
        8.1.2 Argentina
        8.1.3 Rest of Latin America
    8.2 Product Type Segmentation (2017 to 2021f)
        8.2.1 Trivalent Influenza Vaccine
        8.2.2 Quadrivalent Influenza Vaccine
        8.2.3 Others
    8.3 Consumption Segmentation (2017 to 2021f)
        8.3.1 Children
        8.3.2 Adults
        8.3.3 Elderly
        8.3.4 Pregnancy
    8.4  Impact of COVID-19 in Europe
9  MIDDLE EAST AND AFRICA MARKET SEGMENTATION
    9.1 Region Segmentation (2017 to 2021f)
        9.1.1 GCC
        9.1.2 North Africa
        9.1.3 South Africa
        9.1.4 Rest of Middle East and Africa
    9.2 Product Type Segmentation (2017 to 2021f)
        9.2.1 Trivalent Influenza Vaccine
        9.2.2 Quadrivalent Influenza Vaccine
        9.2.3 Others
    9.3 Consumption Segmentation (2017 to 2021f)
        9.3.1 Children
        9.3.2 Adults
        9.3.3 Elderly
        9.3.4 Pregnancy
    9.4  Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
    10.1 Brief Introduction of Major Players
        10.1.1 GSK
        10.1.2 Sinovac
        10.1.3 Changsheng
        10.1.4 CCBIO
        10.1.5 Aleph Biomedical
        10.1.6 Sanofi
        10.1.7 Lanzhou Institute Of Biological Product
        10.1.8 Siobp
        10.1.9 Hualan Bio
        10.1.10 Tianyuan Bio-Pharma
        10.1.11 Vaxtec
        10.1.12 Hissen
        10.1.13 Abbott
        10.1.14 Novartis
        10.1.15 Tasly&Jenner
        10.1.16 Tiantan
    10.2  Influenza Vaccine Sales Date of Major Players (2017-2020e)
        10.2.1 GSK
        10.2.2 Sinovac
        10.2.3 Changsheng
        10.2.4 CCBIO
        10.2.5 Aleph Biomedical
        10.2.6 Sanofi
        10.2.7 Lanzhou Institute Of Biological Product
        10.2.8 Siobp
        10.2.9 Hualan Bio
        10.2.10 Tianyuan Bio-Pharma
        10.2.11 Vaxtec
        10.2.12 Hissen
        10.2.13 Abbott
        10.2.14 Novartis
        10.2.15 Tasly&Jenner
        10.2.16 Tiantan
    10.3  Market Distribution of Major Players
    10.4 Global Competition Segmentation
11  MARKET FORECAST
    11.1  Forecast by Region
    11.2  Forecast by Demand
    11.3  Environment Forecast
        11.3.1  Impact of COVID-19
        11.3.2  Geopolitics Overview
        11.3.3  Economic Overview of Major Countries
12  REPORT SUMMARY STATEMENT
List of Table
Table Influenza Vaccine Product Type Overview
Table Influenza Vaccine Product Type Market Share List
Table Influenza Vaccine Product Type of Major Players
Table Brief Introduction of GSK
Table Brief Introduction of Sinovac
Table Brief Introduction of Changsheng
Table Brief Introduction of CCBIO
Table Brief Introduction of Aleph Biomedical
Table Brief Introduction of Sanofi
Table Brief Introduction of Lanzhou Institute Of Biological Product
Table Brief Introduction of Siobp
Table Brief Introduction of Hualan Bio
Table Brief Introduction of Tianyuan Bio-Pharma
Table Brief Introduction of Vaxtec
Table Brief Introduction of Hissen
Table Brief Introduction of Abbott
Table Brief Introduction of Novartis
Table Brief Introduction of Tasly&Jenner
Table Brief Introduction of Tiantan
Table Products & Services of GSK
Table Products & Services of Sinovac
Table Products & Services of Changsheng
Table Products & Services of CCBIO
Table Products & Services of Aleph Biomedical
Table Products & Services of Sanofi
Table Products & Services of Lanzhou Institute Of Biological Product
Table Products & Services of Siobp
Table Products & Services of Hualan Bio
Table Products & Services of Tianyuan Bio-Pharma
Table Products & Services of Vaxtec
Table Products & Services of Hissen
Table Products & Services of Abbott
Table Products & Services of Novartis
Table Products & Services of Tasly&Jenner
Table Products & Services of Tiantan
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Influenza Vaccine Market Forecast (Million USD) by Region 2021f-2026f
Table Global Influenza Vaccine Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Influenza Vaccine Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Influenza Vaccine Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
Figure Global Influenza Vaccine Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Influenza Vaccine Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Influenza Vaccine Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Influenza Vaccine Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Influenza Vaccine Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Influenza Vaccine Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Influenza Vaccine Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Trivalent Influenza Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Quadrivalent Influenza Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Children Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Adults Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Elderly Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pregnancy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Trivalent Influenza Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Quadrivalent Influenza Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Children Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Adults Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Elderly Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pregnancy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Trivalent Influenza Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Quadrivalent Influenza Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Children Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Adults Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Elderly Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pregnancy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Trivalent Influenza Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Quadrivalent Influenza Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Children Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Adults Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Elderly Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pregnancy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Trivalent Influenza Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Quadrivalent Influenza Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Children Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Adults Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Elderly Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pregnancy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Trivalent Influenza Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Quadrivalent Influenza Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Children Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Adults Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Elderly Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pregnancy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Influenza Vaccine Sales Revenue (Million USD) of GSK 2017-2020e
Figure Influenza Vaccine Sales Revenue (Million USD) of Sinovac 2017-2020e
Figure Influenza Vaccine Sales Revenue (Million USD) of Changsheng 2017-2020e
Figure Influenza Vaccine Sales Revenue (Million USD) of CCBIO 2017-2020e
Figure Influenza Vaccine Sales Revenue (Million USD) of Aleph Biomedical 2017-2020e
Figure Influenza Vaccine Sales Revenue (Million USD) of Sanofi 2017-2020e
Figure Influenza Vaccine Sales Revenue (Million USD) of Lanzhou Institute Of Biological Product 2017-2020e
Figure Influenza Vaccine Sales Revenue (Million USD) of Siobp 2017-2020e
Figure Influenza Vaccine Sales Revenue (Million USD) of Hualan Bio 2017-2020e
Figure Influenza Vaccine Sales Revenue (Million USD) of Tianyuan Bio-Pharma 2017-2020e
Figure Influenza Vaccine Sales Revenue (Million USD) of Vaxtec 2017-2020e
Figure Influenza Vaccine Sales Revenue (Million USD) of Hissen 2017-2020e
Figure Influenza Vaccine Sales Revenue (Million USD) of Abbott 2017-2020e
Figure Influenza Vaccine Sales Revenue (Million USD) of Novartis 2017-2020e
Figure Influenza Vaccine Sales Revenue (Million USD) of Tasly&Jenner 2017-2020e
Figure Influenza Vaccine Sales Revenue (Million USD) of Tiantan 2017-2020e
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Influenza Vaccine Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Influenza Vaccine Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Influenza Vaccine Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports